Critical reviews in oncology/hematologyHumansTriple Negative Breast NeoplasmsImmunotherapySingle-Cell AnalysisTumor Microenvironment
Research progress on immunotherapeutics for triple-negative breast cancer from a single-cell perspective.
Zixuan Yuan, Zhiwei Liu, Mengying Zhou, Huijuan Wen, Bei Li
Published: 202610.1016/j.critrevonc.2025.105111
Abstract
Triple-negative breast cancer (TNBC) is a highly heterogeneous subtype with no effective therapeutic targets. Recent advances in immunotherapy, particularly PD-1/PD-L1 inhibitors and CTLA-4 antibodies, have yielded promising clinical outcomes in some…
Preview only. Read the full abstract at the source